Is constant hair loss giving you nightmares? Choose QR678®
Hair loss, balding or thinning is a prevalent issue that may aggravate anxiety in both men and women. There can be multiple reasons, like androgenetic alopecia or male-pattern baldness, female-pattern hair loss, chemotherapy-induced hair loss, Covid-19-induced hair loss, seborrheic dermatitis, immunogenic diseases like alopecia areata, hair loss because of hormonal imbalances or even stress. Sadly, the majority of available hair loss treatments and medications do not guarantee predictable results. But QR678®, a proprietary, one-ofa-kind treatment for hair loss and hair regrowth, has revolutionised the treatment of alopecia and hair regrowth.
The QR678® formulation is a regulatory-approved, India and USA-patented, and standardised hair restoration method that has benefited more than 100,000 patients successfully. The therapy is also regulatory-approved in the EU, UK, and Kuwait and is pending approval in other countries. The USA and India patents are awarded as this is the first time that hair in the dying phase can be converted to hair in the growing phase (anagen phase). There are more than 12 published clinical trials showcasing results in male-pattern alopecia, femalepattern hair loss, post-chemotherapy hair loss, and diverse hair conditions such as seborrheic dermatitis and alopecia areata. Research has shown a 300% greater efficacy than PRP/GFC.
The regulatory approvals mean its effectiveness and efficacy have been reviewed by the authorities. QR678® has gained an international reputation for producing effective, efficient results that are more predictable than any surgical or non-surgical hair regrowth treatment.
The QR678® is currently manufactured in a cuttingedge WHO cGMP facility in South Korea. For info on your nearest treatment centres, visit www.qr678.in.